Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.61 |
| ▸ | RORC | P51449 | 4/20 | 0.58 |
| ▸ | CNR2 | P34972 | 1/20 | 0.53 |
| ▸ | BCHE | P06276 | 4/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3183297 | 0.98 | HRH3 (0.59) | HRH3RORCCNR2BCHETSHR | |
| SCHEMBL330083 | 0.95 | HRH3 (0.68) | HRH3RORCCNR2BCHETSHR | |
| Hydrochloric Acid SCHEMBL17710415 | 0.93 | HRH3 (0.65) | HRH3RORCCNR2BCHETSHR | |
| Water SCHEMBL28117059 | 0.93 | HRH3 (0.65) | HRH3RORCCNR2BCHETSHR | |
| SCHEMBL20145799 | 0.91 | HRH3 (0.57) | HRH3RORCCNR2BCHETSHR | |
| SCHEMBL9286253 | 0.91 | HRH3 (0.57) | HRH3RORCCNR2BCHETSHR | |
| Hydrochloric Acid SCHEMBL11571118 | 0.89 | HRH3 (0.55) | HRH3RORCCNR2BCHETSHR | |
| SCHEMBL3156308 | 0.88 | MAPT (0.62) | HRH3RORCCNR2BCHEAOC3 | |
| SCHEMBL9485158 | 0.87 | MAPT (0.61) | HRH3RORCBCHETSHRHSD17B10 | |
| SCHEMBL3372139 | 0.87 | HRH3 (0.53) | HRH3RORCCNR2BCHETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10472565-B2 | Low temperature activator systems and methods for chemiluminescent reactions | CYALUME TECHNOLOGIES, INC. (US) | 2019-11-12 | — | — | US | claimed |
| EP-3004286-B1 | BROAD TEMPERATURE PERFORMANCE CHEMILUMINESCENT SYSTEMS AND METHODS | CYALUME TECH INC (US) | 2019-08-28 | — | — | EP | claimed |
| EP-3004286-A1 | BROAD TEMPERATURE PERFORMANCE CHEMILUMINESCENT SYSTEMS AND METHODS | Cyalume Technologies, Inc (US) | 2016-04-13 | — | — | EP | claimed |
| US-9115305-B2 | Broad temperature performance chemiluminescent systems and methods | CYALUME TECHNOLOGIES, INC. (US) | 2015-08-25 | — | — | US | claimed |
| US-20140356975-A1 | LOW TEMPERATURE ACTIVATOR SYSTEMS AND METHODS FOR CHEMILUMINESCENT REACTIONS | Cyalume Technologies (US) | 2014-12-04 | — | — | US | claimed |
| WO-2014194332-A1 | BROAD TEMPERATURE PERFORMANCE CHEMILUMINESCENT SYSTEMS AND METHODS | Cyalume Technologies (US) | 2014-12-04 | — | — | WO | claimed |
| US-20140353559-A1 | BROAD TEMPERATURE PERFORMANCE CHEMILUMINESCENT SYSTEMS AND METHODS | Cyalume Technologies (US) | 2014-12-04 | — | — | US | claimed |
| WO-2024026338-A1 | N-HETEROCYLIC GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | CARMOT THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| EP-3872064-B1 | FLUORINATED IMIDE SALT COMPOUND AND SURFACTANT | MITSUBISHI MAT ELECTRONIC CHEMICALS CO LTD (JP) | 2023-09-20 | — | — | EP | disclosed |
| US-20230079107-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS | CIDARA THERAPEUTICS, INC. | 2023-03-16 | — | — | US | disclosed |
| CN-108778997-B | Method for the rapid calcination of zeolitic materials | 巴斯夫欧洲公司 | 2023-01-17 | — | — | CN | disclosed |
| CN-112996772-B | Fluorine-containing imide salt compound and surfactant | 三菱材料电子化成株式会社 | 2022-10-28 | — | — | CN | disclosed |
| US-11414381-B2 | Fluorinated imide salt compound and surfactant | MITSUBISHI MATERIALS ELECTRONIC CHEMICALS CO., LTD. (JP) | 2022-08-16 | — | — | US | disclosed |
| US-4234723-A | COMPLEXES WITH HYDROXYBENZOATE ANIONS AND AMINE LIGANDS, PHOTOSTABILITY | CIBA-GEIGY CORPORATION (US) | 1980-11-18 | — | — | US | disclosed |
| US-4231921-A | COMPLEX OF A METAL WITH PIPERIDINE WITH ONE ENOLATE GROUP, POLYMERS | CIBA-GEIGY CORPORATION (US) | 1980-11-04 | — | — | US | disclosed |
| US-4186267-A | LIGHT STABILIZERS FOR POLYOLEFINS | CIBA-GEIGY CORPORATION (US) | 1980-01-29 | — | — | US | disclosed |
| EP-0000700-A1 | Metal complexes with a chelating anion comprising a phenolate group, their preparation and their use as light stabilizers, especially for polymeric substances | CIBA-GEIGY AG (CH) | 1979-02-21 | — | — | EP | disclosed |
| EP-0000487-A1 | Compounds containing enol groups, metal chelates made therefrom, their preparation and use as light stabilizers, especially for polymeric substances. | CIBA-GEIGY AG (CH) | 1979-02-07 | — | — | EP | disclosed |
| US-4046788-A | ORTHO- OR PARA-HYDROXYBENZOATE ANIONS, AMINE LIGAND | CIBA-GEIGY CORPORATION (US) | 1977-09-06 | — | — | US | disclosed |
| US-3948852-A | Nickel stabilisers for synthetic polymers | CIBA-GEIGY CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11414381-B2 | Fluorinated imide salt compound and surfactant | NHERF1, AFF1, SCN1A | HRH3 2766/4885RORC 3724/4885CNR2 4187/4885 |
| US-20230079107-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS | FCGR3B, FCGR1A, FCGR2A | HRH3 1600/4885RORC 3919/4885CNR2 2783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.